For drug programmes, Keytruda moved to the 3rd place in the ranking, for which the reimbursement amount in the period from January to July 2021 is 65.8% higher than the reimbursement value in the corresponding period of the previous year.
For drug programmes, Keytruda moved to the 3rd place in the ranking, for which the reimbursement amount in the period from January to July 2021 is 65.8% higher than the reimbursement value in the corresponding period of the previous year.